lobbying_activities: 2033535

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2033535	47a8e406-a03d-4b10-85f6-ef19ce2c8a5d	Q3	KING & SPALDING LLP	21632	SUMITOMO PHARMA AMERICA (FORMERLY SUNOVION PHARMACEUTICALS, INC.)	2017	third_quarter	PHA	Issues related to inclusion of prescription drugs within Essential Health Benefit and mental health coverage expansion	HOUSE OF REPRESENTATIVES,SENATE	10000		0	0	2017-10-19T12:20:27.500000-04:00